Trial intelligence / Profile preview

Allicin for Liver Fibrosis

ChiCTR-IPR-16008207Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Shihezi University
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of allicin in hepatic fibrosis and Cirrhosis, sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoints: Hepatic parameters, Blood coagulation analysis and 3 more. Started Feb 2010; status: recruiting.

02

Drugs

allicin
03

Conditions

hepatic fibrosisCirrhosis

Beyond the preview

Go deeper on ChiCTR-IPR-16008207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call